Ruggiero A, Ariano A, Triarico S, Capozza MA, Romano A, Maurizi P, et al
It slows gastric emptying, blunts appetite, and supports glucose-dependent insulin release
World Obesity calls for: Inclusion of GLP-1 therapies in national essential medicines lists and universal health coverage (UHC) benefit packages Public-sector availability of treatment, not just access via private markets Targeted investment to avoid widening health inequities, particularly for disadvantaged communities Affordable pricing strategies and innovation from manufacturers to expand global access Bridging critical gaps in evidence The introduction of GLP-1 therapies into global health systems must be accompanied by continued research, particularly in areas where evidence is currently thin
Alogliptin added to insulin therapy in patients with type 2 diabetes reduces HbA1c without causing weight gain or increased hypoglycaemia
Effects of pinealectomy on baseline sleep and response to sleep deprivation
To avoid this, gradually add fiber to your diet over a few days, and drink plenty of water